Antiarrhythmic Properties of Beta Blockers: Focus on Nebivolol
International Journal of the Cardiovascular Academy, cilt.10, sa.2, ss.22-30, 2024 (Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 10 Sayı: 2
- Basım Tarihi: 2024
- Doi Numarası: 10.4274/ijca.2024.85057
- Dergi Adı: International Journal of the Cardiovascular Academy
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.22-30
- Anahtar Kelimeler: anti-arrhythmic medications, arrhythmias, Beta-blockers, nebivolol
- Eskişehir Osmangazi Üniversitesi Adresli: Evet
Özet
Beta-blockers are commonly used medications for cardiovascular diseases. Beta-blockers are effective antiarrhythmic agents, and they are class 2 agents in the Vaughan-Williams classification. In this review, we first attempt to mention the physiology of beta-adrenergic activation in the myocardium and the role of excessive beta-adrenergic activation in arrythmiagenesis. Then, we will summarize the pharmacological properties of beta blockers and their use in specific arrhythmias. Special emphasis will be given to nebivolol, a new generation cardioselective beta-blocker with vasodilator activity, given the limited data regarding its use in arrhythmias.